Gland Pharma Limited (GLAND) — Board Meeting

· NSE 🟡 Notable Neutral
📢 Key Event
Independent director Satyanarayana Murthy Chavali resigned effective June 15, 2026 due to potential conflict of interest.
🔄 What Changed
Resignation of independent director Satyanarayana Murthy Chavali effective June 15, 2026.
💡 Investor Takeaway
The resignation may raise governance concerns but does not indicate financial distress or operational disruption.

Gland Pharma disclosed that independent director Satyanarayana Murthy Chavali resigned effective June 15, 2026, citing a potential conflict of interest arising from his promoter role in a company planning to enter a business segment overlapping with Gland Pharma's future plans. The resignation letter confirmed no other material reasons, and the company requested board acknowledgment for statutory filings.

📄 View Original Announcement (PDF)

About Gland Pharma Limited (GLAND)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹30,781.44 Cr P/E: 43.7

View full GLAND stock details →

📡 Get AI alerts when GLAND files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track GLAND — Free

📊 More GLAND filings

See all GLAND filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

📡 Get AI alerts when GLAND files new disclosures

Track GLAND filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track GLAND — Free

Free account · 2 AI queries/day